GLOBAL SARCOMA THERAPY NOW APPROVED FOR NEW ZEALAND PATIENTS

/PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce that its portfolio therapy to treat rare soft tissue...

Related Keywords

Germany ,Australia ,United States ,New Zealand ,Singapore ,Belgium ,Italy ,Austria ,Spain ,Switzerland ,France ,America ,Carlo Montagner ,Denise Caruso ,Jayesh Desai ,Australia Therapeutic Goods Administration ,Cancer Council Victoria Fact Sheet ,European Medicines Agency Summary Of Product Characteristics ,Zealand Sarcoma Association ,Specialised Therapeutics ,Associate Professor Jayesh Desai ,Medical Oncologist ,Deputy Chair ,New Zealand Sarcoma Association ,Executive Officer Dr Denise Caruso ,Therapeutic Goods Administration ,Specialised Therapeutics Asia ,Executive Officer Mr Carlo Montagner ,South East Asia ,North America ,South America ,About Soft Tissue ,Medsafe Approved Data ,European Medicines Agency Summary ,Molecular Spectrum ,